Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 02:34 pm EDT
Artemis Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating income was USD 57,000 compared to USD 70,000 a year ago. Net loss was USD 6,000 compared to USD 69,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating income was USD 76,000 compared to USD 90,000 a year ago. Net loss was USD 27,000 compared to USD 90,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.